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Seventh international symposium on preventive oncology
and intervention strategies brought several scientists and
physicians together in a French city, Nice from 7–10th Feb-
ruary 2004.
The conference covered several contemporary topics like
apoptosis, angiogenesis and several interesting and
insightful talks were presented by the delegates. The key-
note addresses ' Cancer predisposition', on the opening
day by Dr. HT Lynch, the father of lynch syndrome, a
hereditary non polyposis colorectal cancer (HNPCC) is a
highlight of the symposium. There were several talks on
dietary influences, screening and detection, prevention
and intervention, genetic and environmental interactions
and susceptibility genes among many other topics.
As much as it shed spikes of useful information in the field
of preventive oncology, the meeting brought the delegates
to the 'crossroads' of cancer epidemiology. A thought pro-
voking and very interesting closing address 'Cancer Epide-
miology at a Crossroads' by Dr. Eduardo Franco seems to
have summarized and reflected some of the private feel-
ings and thoughts of the practicing scientists and physi-
cians as to what is the right answer for questions like 'what
is the probability of getting cancer for an individual? Does
aspirin cure and prevent colds and cancers alike? Should
we eat more vegetables or beware of trace amounts of pes-
ticides reported to be present in some of them? Are
tobacco and alcohol the sole responsible factors for lung
and upper aero-digestive tract cancers? It all seems to be in
the 'P' value we all dearly believe in, to represent 'proba-
bility' and 'prevention'. Dr. Eduardo Franco rightly sug-
gested, clinical epidemiology is still an evolving discipline
and the best of it is yet come.
A rather interesting set of presentations on the polymor-
phisms of DNA repair and tumor suppressor genes seems
to make his point more eloquent. Polymorphisms in
codon 72 of the p53 gene seem to be a novel 'hot-spot' for
the 'ever hot' tumor suppressor. While correlation or lack
of it with likelihood of cancer predisposition in individu-
als harboring the polymorphic codon is certainly receiv-
ing attention of researchers, culpability of that lone codon
in human cancers is yet to be demonstrated. Is it really rel-
evant to cancer predisposition in humans? It may be a
question of a million dollar grant proposal. May be a cou-
ple.
An interesting introduction by Dr. Horton in his talk on
'HER-2/neu expression and prognosis in breast cancer' is
worth noting. While he was making a case for efficacy of
certain chemotherapeutic drugs in breast cancer patients,
he enumerated the limitations of commonly used
Immuno Histochemistry technique. He pointed out sev-
eral important aspects of the technique that could lead to
subjective evaluation of the expression levels of the pro-
tein leading to ambiguous conclusions. Interestingly, dur-
ing my visit to posters, a researcher sadly noted that in his
hands, only 28% of patients show mutations or/and over
expression of p53 in cancers he is investigating while his
competitors reported 83% of such cases. HPV and cervical
cancers seems to be another topic of less concordant and
more diffuse results.
What is the source of these variations? Demographic dif-
ferences among samples, sample handling, variations in
the technique used and the technician who performed the
technique, experimental bias and inappropriate design of
experiment or a combination of any of these? It is interest-
ing to note that there is no uniformity in the experimental
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procedures and standardized and certified laboratory
practices in biomedical research laboratories. There are no
regulatory bodies to oversee compliance to best labora-
tory practices. We often hear the expression like 'in our
hands, we observe'. I wonder if it is prudent to design,
evolve and follow standardized laboratory techniques and
practices. It might save a lot of time and resources and
accelerate the process of biomedical research. It may result
in conclusions that are meaningful and useful. More
importantly, it may enhance the credibility of biomedical
research among the general public.
On a lighter note, the welcome reception made me believe
that a limited serving of fruits, peanuts, chips, cheese and
wine is the right recipe for a healthy diet. But the reception
on the concluding day seems to suggest that a handful of
peanuts and a glass of red wine may be a sufficient source
of antioxidants and polyunsaturated fatty acids in healthy
diet.
There were several presentations that showed promising
data on the use of soy and tomato among other health
promoting foods in preventing carcinogenesis and cancer.
Yet, there seems to be no NICE way to eat healthy.